Published by Coherent Market Insights
Posted on September 20, 2021
4 min readLast updated: February 5, 2026
The Radiofrequency Ablation Device Market is set to grow due to rising cancer cases and technological advancements, with North America and Asia Pacific as key regions.
Coherent Market Insights released a new market study on 2021-2027 Radiofrequency Ablation Device Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Report offering you more creative solutions that combine our deep geographic experience, intimate sector knowledge and clear insights into how to create value in your business. The research study provides estimates for 2021-2027 Radiofrequency Ablation Device Market Forecast till 2027*.
Request Here For Market Latest Insights: https://www.coherentmarketinsights.com/insight/request-pdf/703
Radiofrequency ablation is a relatively new method of reducing pain associated with back pain. In a recent review published by an organization that studies medical innovations, the Global Commission on Systemic Palliative Care (GCSPC) stated that the most common application for radiofrequency ablation is the treatment of pain in the spine, which has been used since the 1970s. There are many other applications, although these are two examples of the typical type of pain that this device is used to relieve.
Rising prevalence of cancer is expected to drive growth of the global radiofrequency ablation device market during the forecast period. The number of cancer cases has increased over the years globally. According to the World Health Organization (WHO), in 2018, around 18.1 million new cases of cancer and 9.6 million deaths due to cancer were reported globally. According to the same source, around 70% of deaths from cancer occur in emerging economies with lung cancer accounting for the majority of deaths followed by breast cancer. Furthermore, according to the National Cancer Institute, in 2020, around 1,806,590 new cases of cancer are expected to be diagnosed in the U.S. with over 600,000 people dying from this disease. Such high incidence of cancer has led to increased demand for radiofrequency ablation devices. Hence, these factors are expected to drive growth global radiofrequency ablation device market during the forecast period. Furthermore, rising prevalence of cardiovascular disease combined with increasing number of ablation procedures is expected to boost the global radiofrequency ablation device market growth over the forecast period.
However, unfavorable regulatory scenarios combined with high healthcare and maintenance cost is expected to hinder the global radiofrequency ablation device market growth over the forecast period. Furthermore, rising awareness regarding ablation procedures can present lucrative growth opportunities in the global radiofrequency ablation device market. Among regions, North America is expected to witness significant growth in the global radiofrequency ablation device market during the forecast period. This is owing to the high prevalence of cancer combined with the presence of robust healthcare infrastructure in the region. Furthermore, Asia Pacific is expected to register a robust growth rate over the forecast period. This is owing to the introduction of advanced technology such as multi-needle electrode that offers accuracy.
For instance, in June 2020, Boston Scientific Corporation introduced DIRECTSENSE Technology, a tool monitoring the effect of radiofrequency (RF) energy delivery during cardiac ablation procedures.
Radiofrequency Ablation Device Market – Competitive Landscape
Key players functioning in the global prosthetic liners market consists of Boston Scientific, St Jude Medical, Medtronic, Covidien and Stryker, Imricor Medical Systems, AtriCure, BIOTRONIK, MicroPort Scientific and Spacelabs Healthcare.
Purchase this Report at Discount Of US $2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/703
Reasons to Purchase this Report
• Current and future of global Radiofrequency Ablation Device Market outlook in the developed and emerging markets • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period. • Regions/countries that are expected to witness the fastest growth rates during the forecast period • The latest developments, market shares, and strategies that are employed by the major market players
Major Point Answered in Radiofrequency Ablation Device Market Research Study are:
Request Here Sample Report @ https://www.coherentmarketinsights.com/insight/request-sample/703
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Radio Frequency Ablation Device Market Opportunity analysis by major players Boston Scientific, St Jude Medical, Medtronic, Covidien and Stryker appeared first on Gatorledger.
The article discusses the growth and opportunities in the Radiofrequency Ablation Device Market from 2021 to 2027.
Rising cancer prevalence and technological advancements are key drivers of market growth.
North America and Asia Pacific are expected to witness significant growth due to healthcare infrastructure and technology.
Explore more articles in the Research Reports category
